from pharmadata import pharmaverseadam
meta = pharmaverseadam.meta('adlbhy')
print(f"Rows: {meta.number_rows:,} Columns: {meta.number_columns}")Rows: 251 Columns: 14adlbhy
adlbhy
Analysis of Lab Hy’s Law
Structure: One or more records per subject per analysis parameter per analysis timepoint
Variables
Show variable specs
shape: (14, 5)
| variable | label | type | mandatory | role |
|---|---|---|---|---|
| str | str | str | str | str |
| "STUDYID" | "Study Identifier" | "String" | "Yes" | "Identifier Variables for BDS Datasets" |
| "USUBJID" | "Unique Subject Identifier" | "String" | "Yes" | "Identifier Variables for BDS Datasets" |
| "TRT01A" | "Actual Treatment for Period 01" | "String" | "No" | null |
| "ADT" | "Analysis Date" | "Date" | "No" | "Timing Variables for BDS Datasets" |
| "ADY" | "Analysis Relative Day" | "Float64" | "No" | "Timing Variables for BDS Datasets" |
| "AVISIT" | "Analysis Visit" | "String" | "No" | "Timing Variables for BDS Datasets" |
| "PARAM" | "Parameter" | "String" | "Yes" | "Analysis Parameter Variables for BDS Datasets" |
| "PARAMCD" | "Parameter Code" | "String" | "Yes" | "Analysis Parameter Variables for BDS Datasets" |
| "AVAL" | "Analysis Value" | "Float64" | "No" | "Analysis Parameter Variables for BDS Datasets" |
| "AVALC" | "Analysis Value (C)" | "String" | "No" | "Analysis Parameter Variables for BDS Datasets" |
| "CRIT1" | "Analysis Criterion 1" | "String" | "No" | null |
| "CRIT1FL" | "Criterion 1 Evaluation Result Flag" | "String" | "No" | null |
| "ANRHI" | "Analysis Normal Range Upper Limit" | "Float64" | "No" | "Toxicity and Range Variables for BDS Datasets" |
| "LBSEQ" | "Sequence Number" | "Float64" | "No" | null |
Examples
from great_docs import tbl_explorer
from pharmadata import pharmaverseadam
tbl_explorer(pharmaverseadam.adlbhy.head(10))PolarsRows10Columns14 | ||||||||||||||
STUDYID str |
USUBJID str |
TRT01A str |
ADT date |
ADY f64 |
AVISIT str |
PARAM str |
PARAMCD str |
AVAL f64 |
AVALC str |
CRIT1 str |
CRIT1FL str |
ANRHI f64 |
LBSEQ f64 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | CDISCPILOT01 | 01-701-1015 | Placebo | 2013-12-26 | -7 | Baseline | Alanine Aminotransferase (U/L) | ALT | 27 | None | ALT >=3xULN | N | 34 | 3 |
| 1 | CDISCPILOT01 | 01-701-1015 | Placebo | 2014-01-16 | 15 | Week 2 | Alanine Aminotransferase (U/L) | ALT | 41 | None | ALT >=3xULN | N | 34 | 41 |
| 2 | CDISCPILOT01 | 01-701-1015 | Placebo | 2014-01-30 | 29 | Week 4 | Alanine Aminotransferase (U/L) | ALT | 18 | None | ALT >=3xULN | N | 34 | 76 |
| 3 | CDISCPILOT01 | 01-701-1015 | Placebo | 2014-02-12 | 42 | Week 6 | Alanine Aminotransferase (U/L) | ALT | 26 | None | ALT >=3xULN | N | 34 | 106 |
| 4 | CDISCPILOT01 | 01-701-1015 | Placebo | 2014-03-05 | 63 | Week 8 | Alanine Aminotransferase (U/L) | ALT | 22 | None | ALT >=3xULN | N | 34 | 136 |
| 5 | CDISCPILOT01 | 01-701-1015 | Placebo | 2014-03-26 | 84 | Week 12 | Alanine Aminotransferase (U/L) | ALT | 27 | None | ALT >=3xULN | N | 34 | 166 |
| 6 | CDISCPILOT01 | 01-701-1015 | Placebo | 2014-05-07 | 126 | Week 16 | Alanine Aminotransferase (U/L) | ALT | 17 | None | ALT >=3xULN | N | 34 | 201 |
| 7 | CDISCPILOT01 | 01-701-1015 | Placebo | 2014-05-21 | 140 | Week 20 | Alanine Aminotransferase (U/L) | ALT | 21 | None | ALT >=3xULN | N | 34 | 231 |
| 8 | CDISCPILOT01 | 01-701-1015 | Placebo | 2014-06-18 | 168 | Week 24 | Alanine Aminotransferase (U/L) | ALT | 23 | None | ALT >=3xULN | N | 34 | 261 |
| 9 | CDISCPILOT01 | 01-701-1015 | Placebo | 2014-07-02 | 182 | Week 26 | Alanine Aminotransferase (U/L) | ALT | 23 | None | ALT >=3xULN | N | 34 | 296 |